Healthcare - Sector
AcelRx Pharmaceuticals's activity chart (see below) currently has 34 price targets and 28 ratings on display.
Analysts' price targets on this stock were met 46.21% of the time, taking 234.73 days on average.
Most recent stock forecast was given by ED ARCE from WESTPARK on 07-Dec-2023. First documented stock forecast 10-Mar-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Sep-2023
$5
2 years 11 months 14 days ago
(07-Dec-2023)
0/6 (0%)
$4.4 (733.33%)
Buy Since 05-Nov-2018
$4
$9
4 years 11 months 20 days ago
(01-Dec-2021)
2/2 (100%)
$-8.43 (-67.82%)
670
Buy Since 16-Aug-2018
$4
$7
5 years 8 months 5 days ago
(16-Mar-2021)
3/3 (100%)
$-33.2 (-89.25%)
1106
Sell Since 13-Aug-2020
$16.6
$16.8
6 years 15 days ago
(06-Nov-2020)
4/4 (100%)
$-12.4 (-42.76%)
335
Buy Since 16-Aug-2016
$120
$140
7 years 6 months 12 days ago
(09-May-2019)
0/4 (0%)
$56.4 (88.68%)
What is ACRX (AcelRx Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on ACRX (AcelRx Pharmaceuticals)?
Which analyst has the most public recommendations on ACRX (AcelRx Pharmaceuticals)?
Which analyst is the currently most bullish on ACRX (AcelRx Pharmaceuticals)?
Which analyst is the currently most reserved on ACRX (AcelRx Pharmaceuticals)?